Brought to you by
ECR 2019 / C-0980

CT patterns of pseudoprogression and hyperprogression in patients undergoing second-line Nivolumab therapy in NSCLC: do patient’s age and tumour histology predict different response?

Congress:
ECR 2019
Poster Number:
C-0980
Type:
Scientific Exhibit
Keywords:
Lung, Oncology, CT, Chemotherapy, Radiation therapy / Oncology, Cancer, Monoclonal antibodies
Authors:
C. Moroni, D. Cozzi, M. Bartolucci, F. Giannelli, V. Bonti, V. Scotti, F. Mazzoni, V. Miele; Florence/IT
DOI:
10.26044/ecr2019/C-0980

Aims and objectives

Methods and materials

Results

Conclusion

Personal information

References


Home | Browse posters | Help | Privacy policy | Disclamer | Contact | myESR
© 2003-2020 ESR - European Society of Radiology